Revenue cycle leaders: It’s time to retire denial rate as a standalone metric
- At Becker’s 11th Annual Health IT + Digital Health + RCM Conference, four revenue cycle leaders said denial rate on its own no longer tells the full story.
- A low denial rate can hide lost revenue if teams are not pushing for appropriate reimbursement.
- AI that automatically answers additional documentation request (ADR) denials lowers the cost of working a denial, so the old view that some denials are not worth pursuing may no longer hold.
- Low-dollar denials, such as routine venipunctures, add up and deserve the same attention as larger claims.
- Takeaway: RCM metrics must evolve as fast as AI, and teams should understand current workflows before adding AI.
- Source: Becker’s Hospital Review (summary) — read the full article: beckershospitalreview.com/finance/revenue-cycle-management/…
Summarised by the LinkupRCM team for coders, billers and RCM professionals. Have a question about this? Ask in the LinkupRCM community forum.
